Evaluation of Myeloperoxidase/Paraoxonase‐1 Ratio and Dysfunctional HDL Levels in Ankylosing Spondylitis and Their Relationship With Coronary Artery Disease
International Journal of Clinical Practice · 2026-01 · 2026 (1)
DOI: 10.1155/ijcp/2520813 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Practice, online erschienen am 09.03.2026. Verfasst von Yagmur Cagla Reis Altan und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To determine the level of dysfunctional high‐density lipoprotein (dHDL) with the myeloperoxidase/paraoxonase‐1 (MPO/PON‐1) ratio and its relationship with epicardial adipose tissue thickness (EATT) in patients with ankylosing spondylitis (AS).
Methods
Total cholesterol, triglyceride, HDL, low‐density lipoprotein, MPO, and PON‐1 levels of 50 AS patients and 50 healthy volunteers were studied. The MPO/PON‐1 ratio was calculated as the dHDL marker. EATT and ejection fraction of patients and the control group were measured by echocardiography.
Results
There was no difference between the patient and control groups in terms of HDL, LDL, and triglyceride levels ( p > 0.05 for all). A significant difference was detected between the two groups in terms of MPO, PON‐1 levels, MPO/PON‐1 ratio, and EATT ( p < 0.05 for all). While there was a positive correlation between MPO level and MPO/PON‐1 ratio and EATT, a negative correlation was found between PON‐1 level and EATT ( p < 0.05 for all).
Conclusions
We found that the ratio of MPO/PON‐1, which is considered a biochemical marker of coronary artery disease (CAD), is higher in AS patients. Additionally, we demonstrated a significant relationship between EATT and the MPO/PON‐1 ratio. We showed the relationship with the ratio. We think that the MPO/PON‐1 ratio and EATT may be associated with subclinical cardiovascular risk in patients with AS; however, their potential diagnostic utility requires further longitudinal studies specifically designed to evaluate predictive performance.
Zitieren
APA
Altan, Y. C. R., Nacir, B., Alisik, M., Celik, I. E., & Kayahan, S. F. (2026). Evaluation of Myeloperoxidase/Paraoxonase‐1 Ratio and Dysfunctional HDL Levels in Ankylosing Spondylitis and Their Relationship With Coronary Artery Disease. International Journal of Clinical Practice, 2026(1). https://doi.org/10.1155/ijcp/2520813
Vancouver
Altan YCR, Nacir B, Alisik M, Celik IE, Kayahan SF. Evaluation of Myeloperoxidase/Paraoxonase‐1 Ratio and Dysfunctional HDL Levels in Ankylosing Spondylitis and Their Relationship With Coronary Artery Disease. International Journal of Clinical Practice. 2026;2026(1). doi:10.1155/ijcp/2520813
BibTeX
@article{Altan2026,
author = {Altan, Yagmur Cagla Reis and Nacir, Baris and Alisik, Murat and Celik, Ibrahim Etem and Kayahan, Semih Fazli},
title = {Evaluation of Myeloperoxidase/Paraoxonase‐1 Ratio and Dysfunctional HDL Levels in Ankylosing Spondylitis and Their Relationship With Coronary Artery Disease},
journal = {International Journal of Clinical Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijcp/2520813}
}
EUVIMED